Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma

World Journal of Surgery

Volumn 26, Issue 6, 2002, Pages 700-703

  Nakai, Takuya ^a   Koh, Kenzo ^a   Kawabe, Takashi ^a   Shiraishi, Osamu ^a   Okuno, Kiyotaka ^a   Yasutomi, Masayuki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS B ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON B NON C; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SCREENING TEST; SURVIVAL RATE; BLOOD; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HEPATITIS B; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; VIROLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 0036618171     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6244-5     Document Type: Article

References (19)

1. Haratake J, Takeda S, Kasai T, et al. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma. Cancer 1993;72:1178-1183
2. Shuto T, Hirohashi K, Kubo S, et al. Differences of resected hepatocellular carcinoma with hepatitis B or C virus. Hepatogastroenterology 1998;45:1722-1725
3. Chen MF, Jeng LB, Lee WC, et al. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma. Surgery 1998;123:554-559
4. Nagasue N, Ohmori H, Yamanoi A, et al. Different intrahepatic recurrence rate after resection of hepatocellular carcinoma associated with chronic hepatitis B and C. Hepatol. Res. 1998;12:93-110
5. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: tumor multicentricity in cirrhotic liver with hepatitis C. Hepatology 1996;24:307-310
6. Tanabe G, Nuruki K, Baba Y, et al. A comparison of hepatocellular carcinoma associated with HBV or HCV infection. Hepatogastroenterology 1999;46:2442-2446
7. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer 1998;75:347-354
8. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serological status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997;79:1509-1515
9. Lowell JA, Howard TK, White HM, et al. Serological evidence of past hepatitis B infection in liver donor and hepatitis infection in liver allograft. Lancet 1995;345:1084-1085
10. Donovan JP, Schafer DF, Goonewardene T, et al. Development of hepatitis B infection after liver transplantation with donor livers from patients with HBcAb and HbsAb. Hepatology 1994;20:129-134
11. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living transplants. Transplantation 1998;65:494-499
12. Okada S, Sato T, Okusaka T, et al. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease. Br. J. Cancer 1998;77:2028-2031
13. Liver Cancer Study Group of Japan (1997) Classification of Primary Liver Cancer, first English edition, Tokyo, Kanehara, 1-76
14. Wu CC, Ho WL, Chen JT, et al. Hepatitis viral status in patients undergoing liver resection for hepatocellular carcinoma. Br. J. Surg. 1999;86:1391-1396
15. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-963
16. Kim CM, Koike K, Saito I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-320
17. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995;22:1027-1033
18. Takenaka K, Yamamoto K, Taketomi A, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20-24
19. Kubo S, Hirohashi K, Tanaka H, et al. Effect of viral status on recurrence after liver resection for patients with hepatitis B virusrelated hepatocellular carcinoma. Cancer 2000;88:1016-1024